NasdaqCM - Delayed Quote USD
Cognition Therapeutics, Inc. (CGTX)
0.2901
-0.0175
(-5.69%)
At close: June 5 at 4:00:01 PM EDT
0.2990
+0.01
+(3.07%)
Pre-Market: 8:18:25 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-31,107
-28,474
-16,018
-18,533
-3,631
Investing Cash Flow
-4
-4
-147
-171
-27
Financing Cash Flow
12,868
23,565
4,521
5,546
53,201
End Cash Position
16,428
25,009
29,922
41,562
54,721
Capital Expenditure
--
-4
-147
-171
-27
Issuance of Capital Stock
13,533
24,350
5,332
5,324
44,217
Issuance of Debt
--
--
--
--
0
Repayment of Debt
-679
-739
-811
-1,396
-268
Free Cash Flow
-31,111
-28,478
-16,165
-18,704
-3,658
12/31/2021 - 10/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KRON Kronos Bio, Inc.
0.8699
+28.91%
INAB IN8bio, Inc.
0.1201
-1.96%
SILO Silo Pharma, Inc.
0.6400
+12.08%
PHIO Phio Pharmaceuticals Corp.
2.4600
+17.14%
ESLA Estrella Immunopharma, Inc.
1.0600
+7.07%
GLYC GlycoMimetics, Inc.
0.1986
-5.43%
INTS Intensity Therapeutics, Inc.
0.4485
-4.98%
TOVX Theriva Biologics, Inc.
0.4710
+2.84%
ELEV Elevation Oncology, Inc.
0.3051
+0.30%
RENB Renovaro Inc.
0.3128
+5.60%